,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2018-07-15 00:53:00,"Shares of Veeva Systems Inc. (NYSE: VEEV) , the life science industry's leading cloud service provider, rose 39% during the first half of the year, according to data from S&P Global Market Intelligence .",0.9517576098442078,0.0186164453625679,0.029625941067934036,positive,0.9331411719322205
1,2018-07-15 00:53:00,A better-than-expected launch of the company's Vault service keeps giving investors reasons to smile.,0.8811062574386597,0.0330219604074955,0.08587184548377991,positive,0.8480842709541321
2,2018-07-15 00:53:00,"The stock surged furthest this year when the company announced a strong finish to fiscal 2018, which ended in January.",0.9437168836593628,0.023581488057971,0.03270159289240837,positive,0.9201353788375854
3,2018-07-15 00:53:00,Total subscription revenue rose 28% year over year to $554.4 million.,0.9585056900978088,0.018544161692261696,0.022950125858187675,positive,0.9399615526199341
4,2018-07-15 00:53:00,Looking past the top-line growth reveals an even rosier picture.,0.27704301476478577,0.0952315628528595,0.6277254819869995,neutral,0.18181145191192627
5,2018-07-15 00:53:00,"Veeva needs to share revenue from its customer relationship management (CRM) service with Salesforce.com , but the company fully owns its suite of clinical data management products marketed under the Vault brand.",0.023481031879782677,0.021412165835499763,0.9551068544387817,neutral,0.002068866044282913
6,2018-07-15 00:53:00,"During the three months ended in April, Vault revenue comprised 44% of the top line, up from 37% during the same period last year.",0.9571069478988647,0.021917307749390602,0.02097572572529316,positive,0.9351896643638611
7,2018-07-15 00:53:00,"Veeva's a growing company with moving pieces, but it sure looks as if a revenue mix shifting toward Vault is widening profit margins.",0.9304904937744141,0.02682163380086422,0.04268786683678627,positive,0.9036688804626465
8,2018-07-15 00:53:00,"During the fiscal second quarter, the company reported a 32% operating margin that topped the high end of previously issued guidance.",0.919428288936615,0.02175804041326046,0.05881375074386597,positive,0.8976702690124512
9,2018-07-15 00:53:00,"Pharmaceutical companies throw off reams of data that needs to remain accessible for a long time, which makes Veeva's services awfully sticky.",0.03017648495733738,0.9157370924949646,0.0540863573551178,negative,-0.8855606317520142
10,2018-07-15 00:53:00,"Without a viable competitor for clinical data management, Vault could become the Microsoft Office of the biopharma industry and we can already see signs of a network effect .",0.23576658964157104,0.07937333732843399,0.6848600506782532,neutral,0.15639325976371765
11,2018-07-15 00:53:00,"Over the past two years, revenue growth has outpaced sales, general, and administrative (SG&A) costs, and the marketing team doesn't seem to have any trouble retaining clients.",0.599823534488678,0.30950212478637695,0.09067443013191223,positive,0.290321409702301
12,2018-07-15 00:53:00,"Earlier this year, the company reported a 121% revenue retention rate that shows existing customers are sticking around and adding services.",0.6191921234130859,0.29283013939857483,0.08797776699066162,positive,0.3263619840145111
13,2018-07-15 00:53:00,"If Veeva shows further signs it can dominate its niche in the second half of the year, this stock could continue its impressive climb.",0.945905327796936,0.01908624731004238,0.035008419305086136,positive,0.9268190860748291
14,2018-07-15 00:53:00,"10 stocks we like better than Veeva Systems

When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen.",0.12699975073337555,0.025114860385656357,0.8478853702545166,neutral,0.1018848866224289
15,2018-07-15 00:53:00,"After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has quadrupled the market.",0.8087436556816101,0.0373060368001461,0.15395022928714752,positive,0.7714376449584961
16,2018-07-15 00:53:00,"*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Veeva Systems wasn't one of them!",0.2355690747499466,0.014962825924158096,0.7494681477546692,neutral,0.2206062525510788
17,2018-07-15 00:53:00,That's right -- they think these 10 stocks are even better buys.,0.8146857619285583,0.02307075634598732,0.16224350035190582,positive,0.7916150093078613
18,2018-07-15 00:53:00,Click here to learn about these picks!,0.0694708302617073,0.055800698697566986,0.8747285008430481,neutral,0.01367013156414032
19,2018-07-15 00:53:00,Teresa Kersten is an employee of LinkedIn and is a member of The Motley Fool's board of directors.,0.01943996734917164,0.016307445243000984,0.9642525911331177,neutral,0.0031325221061706543
20,2018-07-15 00:53:00,LinkedIn is owned by Microsoft.,0.012965702451765537,0.010095099918544292,0.9769392609596252,neutral,0.002870602533221245
21,2018-07-15 00:53:00,Cory Renauer has no position in any of the stocks mentioned.,0.01182213332504034,0.05994969606399536,0.9282281994819641,neutral,-0.048127561807632446
22,2018-07-15 00:53:00,The Motley Fool owns shares of and recommends Salesforce.com and Veeva Systems.,0.03005971759557724,0.018141884356737137,0.9517984390258789,neutral,0.011917833238840103
23,2018-07-15 00:53:00,The Motley Fool has a disclosure policy .,0.016547108069062233,0.01730392687022686,0.9661489725112915,neutral,-0.0007568188011646271
24,2018-07-15 00:53:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204561054706573,0.01563790813088417,0.9741575717926025,neutral,-0.005433347076177597
